info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Intrauterine Contraceptive Devices Companies

Intrauterine Contraceptive Devices (IUCDs) companies specialize in the development and manufacturing of contraceptive devices designed to be inserted into the uterus to prevent pregnancy. These companies play a crucial role in providing women with effective, long-term contraceptive options. IUCDs, also known as intrauterine devices (IUDs), are T-shaped devices typically made of plastic or metal and may contain hormonal or non-hormonal elements.

Intrauterine Contraceptive Devices CompaniesLatest Intrauterine Contraceptive Devices Companies Update


  • May 2023: Bayer launched heavy menstrual bleeding (HMB), an underdiscussed and underdiagnosed condition, to the attention of the nation by promoting Mirena® (levonorgestrel-releasing intrauterine system) 52 mg, an FDA-approved intrauterine device (IUD) that can be used to treat heavy periods in women who choose IUDs for birth control for up to five years. Bayer's new multi-channel campaign, Seeing Red, is designed to increase public consciousness regarding HMB and a prospective therapeutic alternative. Seeing Red advocates for women throughout the United States to discuss their heavier periods with their healthcare provider in order to determine whether Mirena may be a suitable option. Many women are ignorant that HMB is a medical condition or that treatment options may be available, despite the condition's prevalence and impact. Some have been misinformed or mistakenly believe that heavy periods are a typical occurrence.



  • Society for Family Health (SFH), Population Services International (PSI), and Medicines360 jointly declared the introduction of Avibela (levonorgestrel-releasing intrauterine system) 52 mg in Nigeria. Historically, Nigerian women and girls have had limited access to contraceptive methods. The introduction of Avibela expands the reproductive health options available to women and girls. This signifies the introduction of Medicines360's hormonal intrauterine device (IUD) in its fourth African country, following Kenya, Madagascar, and Zambia. They are able to increase access to a high-quality, cost-effective hormonal IUD through their partnership with PSI and SFH at a time when modern contraception is more crucial than ever. Vital on-the-ground services, such as provider training, quality assurance, product awareness, and local capacity building initiatives, are rendered possible by their partners in order to guarantee sustainable accessibility to the hormonal intrauterine device.


List of Intrauterine Contraceptive Devices Companies in the market

  • Bayer AG

  • Eurogine, S.L.

  • The Cooper Companies, Inc.

  • Pfizer Inc.

  • HLL Lifecare Limited

  • OCON Healthcare

  • SMB Corporation

  • Egemen International

  • Meril Life Sciences Pvt. Ltd.

  • Mona Lisa N.V.

  • Prosan International B.V.

  • Pregna International Limited

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.